# VIEWPOINT MOLECULAR TARGETING, INC.: Antibody-based prertargeted alpha particle therapy for ovarian cancer

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | VIEWPOINT MOLECULAR TARGETING, INC. |
| Location | Coralville, IA |
| Project | Antibody-based prertargeted alpha particle therapy for ovarian cancer |
| Project number | 4R42CA287696-02 |
| Mechanism | R42 |
| Institute | National Cancer Institute |
| Award | $1,006,109 |
| Awarded | 2026-09-17 |
| Project period | 2024-06-05 to 2028-06-30 |
| UEI | RDZCK3F6AU73 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11247612). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.